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NAUSEA INCIDENCE
Figure 1: >1g/day for any duration significantly reduced odds of overall
nausea incidence by 42%. GRADE level: very low
Figure 2: Any dose for >3-days duration significantly reduced odds of
overall nausea incidence by 27%. GRADE level: very low
Ginger for Chemotherapy-induced nausea and vomiting?
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Systematic Review Update with Meta-Analysis
Methods & Included Studies
Introduction
Gingerol and shogaol compounds in ginger likely interact with multiple components of the CINV pathway.
Previous systematic reviews (Marx et. al. 2013 and Lee & Oh 2013) found no consistent effect of ginger as an adjuvant therapy for CINV.
Research aim: To update previous systematic reviews which evaluate the efficacy of ginger supplementation in the prevention and management of CINV
Results
VOMITING INCIDENCE
Figure 3: ≤1g/day for any duration significantly reduced odds of overall
vomiting incidence by 30%. GRADE level: low
Figure 4: Any dose for >3-days duration significantly reduced odds of
overall vomiting by 40%. GRADE level: low
Searched 5 databases → Included adults receiving CTx→ Ginger versus placebo/control (including anti-emetics) → Searched 204 records → Included 18 
studies (13 new ones) → n=1,652 total participants, 64% female , n=9/18 studies in breast cancer→ Low risk of bias in most studies (Cochrane) →Meta-
analysis via RevMan→ Confidence in body of evidence assessed by GRADE.
Takeaway messages
✓ No serious safety concerns identified beyond increased risk of reflux
✓ Consistent finding that >3 days of supplementation can improve nausea & vomiting incidence
✓ Evidence regarding dosing strength inconsistent likely to due to heterogeneity in active compounds
✓ Larger well-controlled studies should improve confidence in estimated effect sizes
✓ SPICE Trial currently underway in Qld Australia (n=300 Double Blind Placebo-RCT)
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